Abstract:Background: The recent pandemic of obesity and the metabolic syndrome (MetS) has led to the realisation that new drug targets are needed to either reduce obesity or the subsequent pathophysiological consequences associated with excess weight gain. Certain nuclear hormone receptors (NRs) play a pivotal role in lipid and carbohydrate metabolism and have been highlighted as potential treatments for obesity. This realisation started a search for NR agonists in order to understand and successfully treat MetS and associated conditions such as insulin resistance, dyslipidaemia, hypertension, hypertriglyceridemia, obesity and cardiovascular disease. The most studied NRs for treating metabolic diseases are the peroxisome proliferator-activated receptors (PPARs), PPAR-α, PPAR-γ, and PPAR-δ. However, prolonged PPAR treatment in animal models has led to adverse side effects including increased risk of a number of cancers, but how these receptors change metabolism long term in terms of pathology, despite many beneficial effects shorter term, is not fully understood. In the current study, changes in male Sprague Dawley rat liver caused by dietary treatment with a PPAR-pan (PPAR-α, -γ, and -δ) agonist were profiled by classical toxicology (clinical chemistry) and high throughput metabolomics and lipidomics approaches using mass spectrometry. Results: In order to integrate an extensive set of nine different multivariate metabolic and lipidomics datasets with classical toxicological parameters we developed a hypotheses free, data driven machine learning approach. From the data analysis, we examined how the nine datasets were able to model dose and clinical chemistry results, with the different datasets having very different information content. Conclusions: We found lipidomics (Direct Infusion-Mass Spectrometry) data the most predictive for different dose responses. In addition, associations with the metabolic and lipidomic data with aspartate amino transaminase (AST), a hepatic leakage enzyme to assess organ damage, and albumin, indicative of altered liver synthetic function, were established. Furthermore, by establishing correlations and network connections between eicosanoids, phospholipids and triacylglycerols, we provide evidence that these lipids function as a key link between inflammatory processes and intermediary metabolism.

An Ensemble Metabolome-Epigenome Interaction Network Identifies Metabolite Modulators of Epigenetic Drugs

Methyl-Metabolite Depletion Elicits Coordinated Responses to Support Heterochromatin Stability and Epigenetic Persistence

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Recon8D: A metabolic regulome network from oct-omics and machine learning

[Indication and results of autogenous tooth transplantation].

A combinatorial domain screening platform reveals epigenetic effector interactions for transcriptional perturbation

Regulatory Roles of Metabolites in Cell Signaling Networks

Epigenomic manipulation reveals the relationship between locus specific chromatin dynamics and gene expression

Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenase

Metabolite regulation of epigenetics in cancer

Integration of metabolomics, lipidomics and clinical data using a machine learning method

Single cell proteomics by mass spectrometry reveals deep epigenetic insight into the actions of an orphan histone deacetylase inhibitor

Stitching Together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation

Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition

Single-cell profiling of small molecule-genomic interactions and epigenetic states

Specific regulation of epigenome landscape by metabolic enzymes and metabolites

Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction

Epigenetic control of metabolic identity across cell types

Metabolic enzymes function as epigenetic modulators: A Trojan Horse for chromatin regulation and gene expression

Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors